2025-07-19 - Analysis Report
Okay, here's an analysis of Hims & Hers Health Inc. (HIMS) based on the provided data. The report is in English, with numerical data and brief analysis for each section, followed by a comprehensive summary.

**Hims & Hers Health Inc. (HIMS) Analysis**

**0. Introduction**

This report analyzes the performance of Hims & Hers Health Inc. (HIMS), a company focused on providing telehealth services and personalized health products. We will examine its stock performance relative to the S&P 500 (VOO), recent price movements, market risk indicators, recent news, and financial data.

**1. Performance Relative to S&P 500 (VOO)**

*   **Ticker:** HIMS
*   **Company:** Hims & Hers Health Inc (Provides telehealth services and personalized health products)
*   **HIMS Cumulative Return:** 179.44%
*   **VOO (S&P 500) Cumulative Return:** 65.31%
*   **Spread (Difference):**
    *   Max: 288.9
    *   Min: -88.4
    *   Current: 116.5
    *   Relative Spread: 54.3

**Analysis:** HIMS has significantly outperformed the S&P 500 based on cumulative returns. The current spread of 116.5 indicates a considerable difference in performance. The Relative Spread of 54.3 suggests that the current spread is somewhat in the middle range of its historical spread.

**Alpha, Beta Analysis:**

| Year       | CAGR     | MDD    | Alpha   | Beta   | Cap(B) |
|------------|----------|--------|---------|--------|--------|
| 2019-2021  | -46.0%   | 51.0%  | -84.0%  | -0.0   | 1.5    |
| 2020-2022  | -15.0%   | 72.1%  | -17.0%  | -0.0   | 1.4    |
| 2021-2023  | -51.0%   | 72.1%  | -69.0%  | -0.1   | 2.0    |
| 2022-2024  | 127.0%   | 78.4%  | 101.0%  | -0.1   | 5.4    |
| 2023-2025  | 174.0%   | 78.4%  | 126.0%  | -0.1   | 11.3   |

**Analysis:**

*   **CAGR (Compound Annual Growth Rate):**  The CAGR shows significant volatility. Early periods (2019-2023) show negative growth, while recent periods (2022-2025) display substantial positive growth, indicating a recent turnaround.
*   **MDD (Maximum Drawdown):**  The MDD is consistently high, suggesting significant risk and potential for losses.
*   **Alpha:**  Alpha values are largely negative in earlier periods but turn strongly positive recently, reinforcing the trend of recent outperformance.  A large positive alpha indicates HIMS has outperformed its benchmark (likely the S&P 500) on a risk-adjusted basis.
*   **Beta:**  Beta values are close to zero or slightly negative, which is unusual. Ideally, Beta indicates the volatility of the security compared to the market.
*   **Cap(B):**  Market capitalization has increased significantly in recent years.

**2. Recent Price Action**

*   **Current Price:** 50.38
*   **Last Market Data:** price = 50.38, previousClose = 49.99, change = 0.78
*   **5-Day Moving Average:** 50.942
*   **20-Day Moving Average:** 49.1365
*   **60-Day Moving Average:** 50.5342

**Analysis:** The current price is above the 20-day moving average but below the 5-day and 60-day moving averages. This suggests a potential short-term pullback after a recent upward trend.

**3. Market Risk Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.3399 (Low Risk)
*   **RSI:** 52.51
*   **PPO:** 0.4268
*   **Hybrid Signal:** cash\_0% Buy 80% of cash (3 shares - Caution - MRI:0.34) (Cash Ratio: 0% on 2025-07-18)
*   **Recent (20-day) Relative Spread Change:** -0.9 (Negative – Short-term Decline)
*   **Expected Return:** -16.5% (Long-term, relative to S&P 500)

**Analysis:**

*   **MRI:** The MRI indicates low market risk.
*   **RSI:** The RSI is near the neutral level, suggesting neither overbought nor oversold conditions.
*   **PPO:** The Positive Percentage Oscillator (PPO) is a momentum oscillator that measures the difference between two moving averages as a percentage of the longer moving average.
*   **Hybrid Signal:** The Hybrid Signal recommends a high allocation to HIMS, but with caution, as indicated by the MRI.
*   **Relative Spread Change:** The negative change in relative spread suggests underperformance relative to the S&P 500 in the short term.
*   **Expected Return:** The negative expected return suggests that, based on the model, HIMS is expected to underperform the S&P 500 over the long term if investing from the current position.
*   **Recent Price Change:** The positive change from the previous close suggests a recent small upward price movement, potentially triggered by recent volatility.

**4. Recent News & Significant Events**

*   **2025-07-15:** Major business developments, regulatory changes, or market events.
*   **2025-07-17:** Analysts discussing recent performance and outlook.
*   **2025-07-19:** Notable stock volatility influenced by recent news, earnings reports, or executive actions.
*   **2025-07-18:** Market experts highlight both risks and opportunities.

**Analysis:** Recent news indicates volatility and active discussion surrounding HIMS, suggesting potential catalysts for price movement. Investors should monitor news and company announcements closely.

**5. Recent Earnings Analysis**

| 날짜       | EPS    | 매출        |
|------------|--------|-------------|
| 2025-05-05 | 0.22   | 0.59 B$     |
| 2024-11-04 | 0.35   | 0.40 B$     |
| 2024-08-05 | 0.06   | 0.32 B$     |
| 2024-05-06 | 0.05   | 0.28 B$     |
| 2025-05-05 | 0.05   | 0.28 B$     |

**Analysis:**

*   **EPS (Earnings Per Share):** EPS has fluctuated, with a recent high in 2024-11-04 (0.35) but then decreased by the end of the next period.
*   **Revenue:** Revenue has been generally increasing, indicating growth in the company's top line.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-03-31 | $0.59B  | 73.50%        |
| 2024-12-31 | $0.48B  | 76.81%        |
| 2024-09-30 | $0.40B  | 79.16%        |
| 2024-06-30 | $0.32B  | 81.30%        |
| 2024-03-31 | $0.28B  | 82.36%        |

**Analysis:**

*   **Revenue:**  Revenue has shown consistent growth over the reported quarters.
*   **Profit Margin:** Profit margins have been decreasing, which could be a concern. Increased revenue must be converted into profitability.

**Capital and Profitability:**

| Quarter    | Equity  | ROE   |
|------------|---------|-------|
| 2025-03-31 | $0.55B  | 9.01%  |
| 2024-12-31 | $0.48B  | 5.46%  |
| 2024-09-30 | $0.44B  | 17.18% |
| 2024-06-30 | $0.36B  | 3.67%  |
| 2024-03-31 | $0.34B  | 3.23%  |

**Analysis:**

*   **Equity:**  Equity has increased steadily, indicating a strengthening financial position.
*   **ROE (Return on Equity):** ROE has fluctuated, with a high point, but has generally increased overall, indicating improved profitability relative to equity.

**7. Overall Analysis & Summary**

Hims & Hers Health Inc. (HIMS) has demonstrated significant outperformance compared to the S&P 500 in the past, although recent data suggests this trend may be weakening.

**Key Observations:**

*   **Performance:** Historically strong outperformance relative to the S&P 500, but recent data indicates a short-term decline in relative performance.
*   **Risk:** High MDD indicates considerable risk. The MRI suggests a low market risk environment currently.
*   **Financials:**  Revenue is growing, but profit margins are decreasing. Equity is increasing, and ROE has improved overall.
*   **Market Sentiment:** Recent news suggests volatility and active market discussion, indicating potential catalysts for price movement.
*   **Technicals:** Price action shows a potential short-term pullback.
*   **Expected Return:** The model predicts underperformance compared to the S&P 500 over the long term.

**Conclusion:**

HIMS presents a mixed picture. While it has shown strong growth and outperformance in the past, recent trends suggest caution. Decreasing profit margins, a negative expected return (relative to the S&P 500), and potential short-term pullback are areas of concern. Investors should carefully monitor news, earnings reports, and financial data before making investment decisions. The company's ability to maintain revenue growth while improving profitability will be crucial for its long-term success.
